Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiency

Droghini, H. R., Abonia, J. P., Collins, M. H., Milner, J. D., Lyons, J. J., Freeman, A. F., Mukkada, V. A., Risma, K. A., Rothenberg, M. E., & Schwartz, J. T. (2022). Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiency. The Journal of Allergy and Clinical Immunology: In Practice, 10(7), 1903–1906. https://doi.org/10.1016/j.jaip.2022.01.012
Authors:
H. Richard Droghini
J. Pablo Abonia
Margaret H. Collins
Joshua D. Milner
Jonathan J. Lyons
Alexandra F. Freeman
Vincent A. Mukkada
Kimberly A. Risma
Marc E. Rothenberg
Justin T. Schwartz
Affiliated Authors:
Joshua D. Milner
Subjects:
Publication Type:
Article
Unique ID:
10.1016/j.jaip.2022.01.012
PMID:
Publication Date:
Data Source:
Scopus

Record Created: